Paul Davis

[email protected]

Responsive - Making the most of the new banner ad formats

August 5, 2014

Page Layout Showing A Portrait Ad And Its Expansion Dimensions

Responsive - The Power of Landing Pages

August 5, 2014

2015 06 24 17 50 06 429 Inline

Responsive - 7 Deadly Sins of Landing Page Design

August 5, 2014

Responsive - 5 Short Videos to help you improve your eBroadcasts

August 5, 2014

Mismatched Goals

June 29, 2009

Lost in Translation...

February 5, 2008

2008 03 14 14 48 17 706

Agents of Change: The new wave of crawlers, spiders and bots

March 13, 2006

Defining your success

June 7, 2005

Defining your success

June 5, 2005

Rich Media: The power of being rich

March 30, 2005

Page 2 of 3

A 68Ga-RCC78 PET scan (C) of a patient four years post-radical right nephrectomy. During follow-up, new nodules were detected in the left adrenal gland and kidney. CAIX-targeted scan clearly visualized metastatic lesions in the mediastinum, pancreas, adrenal gland, and kidney (SUVmax > 30), demonstrating the tracer's ability to maintain high tumor uptake despite significantly reduced abdominal background.

SNMMI: CAIX-targeted PET tracer detects clear cell renal cell carcinoma

Researchers aim for "more precise molecular map" for kidney cancer.

Snmmi Thumb

SNMMI: Low-cost absorbents clear over 90% of Lu-177 from wastewater

(Left) F-18 GP1 PET/CT images from a 75-year-old woman show multiple blood clots in the deep veins of the left leg (from the thigh to the calf), as well as several clots in the right calf. Venous ultrasound confirms blood clots in left thigh, knee and calf veins. PET/CT also detects clots in both lungs, which are confirmed by contrast-enhanced CT image. (Right) 18F-GP1 PET/CT images from a 70-year-old woman show widespread blood clots throughout the body. In addition to clots in the deep veins of both legs and the arteries of both lungs (A), the scan also detected unexpected clots in several other areas, including blood vessels near the skull/head (B), spine (C), heart (D), and pelvis (E). Further evaluation revealed that the patient had antiphospholipid syndrome, an autoimmune condition that increases the risk of abnormal blood clot formation.

SNMMI: PET tracer that detects deep vein thrombosis wins Image of the Year

Static PET-CT image of patient with hypercortisolism taken at 60 minutes post-injection.

SNMMI: Novel radiotracer effectively images overactive adrenal glands

Mouaz Al Mallah Thumb1

SNMMI: Mouaz Al-Mallah discusses cardiac PET

SNMMI: PET tracer detects both cardiac Inflammation and tumor activity

CCR2 is expressed in both atherosclerotic plaques and tumors.

May 31, 2026

Combination therapy of JAK1i with anti-PD1 slows down tumor growth and reduces CCR2+ cells infiltration in atherosclerotic lesions compared to anti-PD1 alone. Representative PET images of cardio-oncology mice treated with anti-PD1 alone or in combination with JAK1i. The PET uptake was normalized by subtracting blood retention.

SNMMI: Prostate cancer vaccines may improve response to Pluvicto

Immunological priming before radiopharmaceutical therapy may enhance clinical efficacy without impairing prostate antigen-specific T-cell response.

May 31, 2026

ASCO: Lu-177 edotreotide yields sustained quality-of-life gains

By Erik L. Ridley

A poster presentation at ASCO 2026 highlighted quantifiable benefits for patients receiving the radiopharmaceutical treatment for GEP-NETs.

May 31, 2026

SNMMI: Jeremie Calais discusses theranostics (and football)

Jeremie Calais, MD, of the University of California, Los Angeles, discussed the present state of the field of theranostics, as well as it’s future potential.

May 31, 2026

SNMMI: Phillip Kuo discusses Alzheimer’s disease imaging and treatment

Phillip Kuo, MD, PhD, discussed developments in diagnosing and treating Alzheimer’s disease at the SNMMI meeting.

May 31, 2026

SNMMI: Music relieves anxiety, cuts perceived SPECT/CT scan time

By Kate Madden Yee

Research findings could improve the experience of patients undergoing these exams as well as the quality of the imaging itself.

May 31, 2026

SNMMI: New brain imaging agent tracks progressive supranuclear palsy

By Kate Madden Yee

The tracer, called [F-18] OXD-2314, successfully identified abnormal proteins in key brain regions of patients with the disease.

May 31, 2026

SNMMI: Machine-learning model predicts RPT dose

Dosimetry plays a central role in optimizing lutetium-177 (Lu-177) PSMA therapy, yet calculating it currently depends on post-therapy imaging.

May 30, 2026

ASCO: Surveillance MRI boosts breast cancer detection for Black women

By Erik L. Ridley

Surveillance breast MRI could potentially reduce persistent racial disparities in breast cancer outcomes, according to a study presented at ASCO 2026.

May 30, 2026

SNMMI: Text confirmations cut PET/CT cancellations by 73.5%

Common causes of appointment cancellations include patient no-shows, same-day cancellations for personal reasons, non-compliance with pre-procedural instructions, and abnormal blood glucose.

May 30, 2026

Kiara Schmidt of Froedtert Health presented a study May 30 at the SNMMI annual meeting.

SNMMI: Vaccination misreporting puts FDG PET cancer reads at risk

By Kate Madden Yee

Vaccinations can prompt FDG uptake in lymph nodes that make interpretation of F-18 FDG PET scans tricky.

May 30, 2026

AIUM: Capacity building needed for global ultrasound initiatives

By Amerigo Allegretto

Ultrasound is useful in low-resource settings, but imagers in global health have some important considerations to make.

May 30, 2026

Page 2 of 230